Vol. 49, No. 3, Feb. 2022
The 12th Annual Meeting of the Japanese Association of Pharmaceutical Medicine 2021 /
Perspectives for overcoming the COVID-19 pandemic: Science, society and medicine: the 2nd session
 
Contents
 
EditorialTsubaki H 340-1Full text
 
Lecture
 The 12th Annual Meeting of the Japanese Association
  of Pharmaceutical Medicine 2021-A new style of pharmaceutical medicine
   (President: Kotone Matsuyama)
    <Keynote lecture> Clinical Practice for COVID-19
Ohmagari N
 Chaired by Seriu T
 Graphic recording by Yoshikawa K
 Co-organized by EP-CRSU CO., LTD.
343-60Abstract
 
Round table discussion
 Perspectives for overcoming the COVID-19 pandemic:
  Science, society and medicine: the 2nd session
   -Overviewing our two-year experience-
Tsubaki H,Funatogawa I,Saito M,
Endo K,Kasanuki H
 Organized by Kurihara C,Saio T
361-434Abstract
 
Articles
 Statistical aspects of safety-related clinical assessmentTsubaki H 435-41Abstract
 Analysis of epidemiological data including an interaction in symptom occurrence
  -From the “Nagoya City Cervical Cancer Vaccination Survey”
Shitara S,Morikawa T 443-81Full text
 Comparison between two papers analyzing data
  from the “Nagoya City Cervical Cancer Immunization Program Survey Results”
Yaju Y 483-98Full text
 Overview of COVID-19 post-vaccination mortality
  and pharmacoepidemiological evaluation: nation-wide view and a proposal
Fukushima M,Hirai Y,Nakatani E,
Nishimura T
499-517Full text
 PTSD without trauma: to reconstruct stress-related disordersSaio T 519-30Abstract
 
Forum
 Bioethics Seminar organized by and for patient and public
  Civic Action to link the lives for our future
Kurihara C,Uchida E,Murakami T,
Kai H,Suzuki K,Inoue K
531-8Full text
 
Instructions for authors[Japanese]&[English] 541-9Full text
 
Editor’s noteKurihara M 551Full text

Back to Rinsho Hyoka(Clinical Evaluation) home page
Back to Contents